Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-305 in blepharitis
NCT01543490Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Mar 2018
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in blepharitis, sponsored by Sun Pharma. Started Mar 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT01543490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543490.